NCT03544944View on ClinicalTrials.gov

A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy

PHASE3CompletedINTERVENTIONAL
Enrollment

297

Participants

Timeline

Start Date

January 2, 2018

Primary Completion Date

May 30, 2018

Study Completion Date

July 30, 2018

Conditions
Bowel Preparation
Interventions
DRUG

TJP-008-1

Subjects who are randomized into group TJP-008-1 will receive bowel preparation on the same-day.

DRUG

TJP-008-2

Subjects who are randomized into group TJP-008-2 will receive bowel preparation from evening to next morning.

DRUG

Coolprep powder

Subjects who are randomized into group Coolprep will receive bowel preparation from evening to next morning.

Trial Locations (1)

Unknown

Taejoon Pharmaceutical Co., Ltd., Seoul

All Listed Sponsors
lead

Taejoon Pharmaceutical Co., Ltd.

INDUSTRY

NCT03544944 - A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy | Biotech Hunter | Biotech Hunter